Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Pandion Therapeutics, Inc. (PAND)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-20Dec-31-19
   10-K10-K
Net income  -43.0-25.9
Depreciation and amortization   [+]0.50.2
Stock-based compensation  2.60.1
Change in working capital   [+]-0.28.2
Other operating activities  5.03.9
Cash from operations  -35.0-13.4
   
Capital expenditures  -2.8-0.6
Cash from investing  -2.8-0.6
   
Issuance of common stock, net  152.9 
Financing costs   -0.1
Other cash from financing  89.319.8
Cash from financing  242.219.9
   
Free cash flow  -37.8-14.1
        Per share (diluted)  ($2.79)($13.60)
   
Cash paid for interest  0.10.0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy